ERBB2 and breast cancer: Because epithelial-to-mesenchymal transition (EMT) plays a critical role in invasion and metastasis of OS [24] and cucurbitacin B (CuB), a close analogue of CuE, mediated HER2/TGFβ inhibition lead to suppression of EMT in breast cancer cells [25].